Implantica AG SDR
Implantica AG is a Swiss medical technology company dedicated to the development of advanced advanced e-health and miniaturized implantable medical devices. The company designs and manufactures proprietary wireless-powered electronic implants, prominently featuring RefluxStop, an innovative implantable surgical device designed to treat gastroesophageal reflux disease by effectively restoring native anatomy without altering food passages. Its core operations encompass biomedical device engineering, clinical trial research, regulatory compliance, and international medical product commercialization. Revenue is derived primarily from the commercial sales of RefluxStop in approved European healthcare markets. Implantica holds a specialized, innovative position in surgical medical technology and gastrointestinal treatments. The company is headquartered in Vaduz, Liechtenstein, with operating facilities in Switzerland, and its Swedish Depository Receipts trade on Nasdaq Stockholm.
2 of the funds FundTelligence covers report a position in Implantica AG SDR.
- Sector
- Health Care
- Country
- Liechtenstein
- Funds holding it
- 2
Funds holding Implantica AG SDR
- Handelsbanken Microcap Norden — Handelsbanken · 3.55 % (full portfolio disclosed, October 2026)
- Handelsbanken Nordiske SMB — Handelsbanken · 0.48 % (full portfolio disclosed, October 2026)